4) CBIPR-BSL4 RIID

Abstract

Performs T&E and provides the essential data packages to support US Food and Drug Administration approval of leading biodefense medical countermeasure candidates to protect the Warfighter and the Nation

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2023
Source ID
bd64d6167fe0bc9bca1b89053ee10347

Related Documents